SCINAI IMMUNOTHERAPEUTICS LTD. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SCINAI IMMUNOTHERAPEUTICS LTD. stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $704.00K.
- SCINAI IMMUNOTHERAPEUTICS LTD. stock issued during period, value, stock options exercised for the quarter ending 2023-03-31 was $97.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-12-31 | $1.44M 20-F · filed 2025-05-07 | |
| 2023-12-31 | $801.00K 20-F · filed 2025-05-07 | |
| 2023-06-30 | $704.00K 6-K/A · filed 2023-08-18 | |
| 2023-03-31 | $97.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $250.00K 20-F · filed 2025-05-07 |